SignalStack
Back to feed

Finding New Drugs Is Laborious. This AI Startup Is Skipping The Lab Work

Read original

AI summary

Potential Sciences uses AI trained on computer-generated data to bypass slow lab work, aiming to accelerate the development of new drugs.

AI-generated summary. Check the original reporting for context and accuracy.

Source excerpt

This is the available feed excerpt, which may be shortened or in the publisher’s original language.

Potential Sciences, a startup backed by the UK government, is betting that training AI models on computer-generated biochemical data can speed up the plodding process of developing new drugs.

About priority

An automated sorting aid based on source trust, keywords, and entities, on a scale of 1–12. High: 9–12; medium: 6–8; low: 1–5. It does not measure urgency, verify reporting, or indicate editorial endorsement.

More in this topic